These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36094767)

  • 21. Characterization of a novel bullet-shaped lytic bacteriophage against extensively drug-resistant
    Barazandeh M; Shahin K; Hedayatkhah A; Komijani M; Mansoorianfar M
    Vet Res Forum; 2021 Dec; 12(4):401-407. PubMed ID: 35529810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of lytic bacteriophages against
    Majdani R; Shams Ghahfarokhi E
    Iran J Microbiol; 2022 Apr; 14(2):203-213. PubMed ID: 35765555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant
    Amankwah S; Adisu M; Gorems K; Abdella K; Kassa T
    Infect Drug Resist; 2022; 15():2797-2811. PubMed ID: 35668859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
    Alves DR; Perez-Esteban P; Kot W; Bean JE; Arnot T; Hansen LH; Enright MC; Jenkins AT
    Microb Biotechnol; 2016 Jan; 9(1):61-74. PubMed ID: 26347362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa.
    Maharjan A; Nepal R; Dhungana G; Parajuli A; Regmi M; Upadhyaya E; Mandal D; Shrestha M; Pradhan P; Manandhar KD; Malla R
    J Nepal Health Res Counc; 2022 Mar; 19(4):717-724. PubMed ID: 35615828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments.
    Vieira A; Silva YJ; Cunha A; Gomes NC; Ackermann HW; Almeida A
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3241-9. PubMed ID: 22777594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and
    Harada LK; Silva EC; Rossi FP; Cieza B; Oliveira TJ; Pereira C; Tomazetto G; Silva BB; Squina FM; Vila MM; Setubal JC; Ha T; da Silva AM; Balcão VM
    Future Microbiol; 2022 Jan; 17():111-141. PubMed ID: 34989245
    [No Abstract]   [Full Text] [Related]  

  • 28. Survival Comes at a Cost: A Coevolution of Phage and Its Host Leads to Phage Resistance and Antibiotic Sensitivity of
    Koderi Valappil S; Shetty P; Deim Z; Terhes G; Urbán E; Váczi S; Patai R; Polgár T; Pertics BZ; Schneider G; Kovács T; Rákhely G
    Front Microbiol; 2021; 12():783722. PubMed ID: 34925289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage therapy as an alternative technique for treatment of multidrug-resistant bacteria causing diabetic foot infection.
    Ghanaim AM; Foaad MA; Gomaa EZ; Dougdoug KAE; Mohamed GE; Arisha AH; Khamis T
    Int Microbiol; 2023 May; 26(2):343-359. PubMed ID: 36350460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
    Pallavali RR; Degati VL; Lomada D; Reddy MC; Durbaka VRP
    PLoS One; 2017; 12(7):e0179245. PubMed ID: 28719657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
    Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
    J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A virulent phage JHP against Pseudomonas aeruginosa showed infectivity against multiple genera.
    Khawaja KA; Rauf M; Abbas Z; Rehman SU
    J Basic Microbiol; 2016 Oct; 56(10):1090-1097. PubMed ID: 27106788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential therapeutic impact of a topical bacteriophage preparation in treating
    Piranaghl H; Golmohammadzadeh S; Soheili V; Noghabi ZS; Memar B; Jalali SM; Taherzadeh Z; Fazly Bazzaz BS
    Heliyon; 2023 Jul; 9(7):e18246. PubMed ID: 37539104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by
    Fiscarelli EV; Rossitto M; Rosati P; Essa N; Crocetta V; Di Giulio A; Lupetti V; Di Bonaventura G; Pompilio A
    Microorganisms; 2021 Feb; 9(3):. PubMed ID: 33668889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic Killing and Re-Sensitization of
    Engeman E; Freyberger HR; Corey BW; Ward AM; He Y; Nikolich MP; Filippov AA; Tyner SD; Jacobs AC
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33668899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Novel Bacteriophages Improve Survival in
    Jeon J; Yong D
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of
    Yang L; Zhang T; Li L; Zheng C; Tan D; Wu N; Wang M; Zhu T
    Front Microbiol; 2022; 13():907958. PubMed ID: 35847060
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of expanded host range phage active on biofilms of multi-drug resistant
    Mapes AC; Trautner BW; Liao KS; Ramig RF
    Bacteriophage; 2016; 6(1):e1096995. PubMed ID: 27144083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage.
    Ahiwale S; Tamboli N; Thorat K; Kulkarni R; Ackermann H; Kapadnis B
    Curr Microbiol; 2011 Feb; 62(2):335-40. PubMed ID: 20711581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.